Motor protein-dependent membrane trafficking of KCl cotransporter-4 is important for cancer cell invasion.
The KCl cotransporter (KCC) is a major determinant of osmotic homeostasis and plays an emerging role in tumor biology. This study stresses the important role of KCC4 in tumor malignant behavior. Real-time reverse transcription-PCR on samples collected by laser microdissection and immunofluorescent stainings with different KCC isoform antibodies indicate that KCC4 is abundant in metastatic cervical and ovarian cancer tissues. Insulin-like growth factor I (IGF-I) and epidermal growth factor (EGF) stimulate KCC4 recruitment from a presumably inactive cytoplasmic pool of endoplasmic reticulum and Golgi to plasma membrane along actin cytoskeleton that is significantly inhibited by LY294002 and wortmannin. Throughout the trafficking process, KCC4 is incorporated into lipid rafts that function as a platform for the association between KCC4 and myosin Va, an actin-dependent motor protein. KCC4 and ezrin, a membrane cytoskeleton linker, colocalize at lamellipodia of migratory cancer cells. Interference with KCC activity by either an inhibitor or a dominant-negative loss-of-function mutant profoundly suppressed the IGF-I-induced membrane trafficking of KCC4 and the structural interaction between KCC4 and ezrin near the cell surface. Endogenous cancer cell invasiveness was significantly attenuated by small interfering RNA targeting KCC4, and the residual invasiveness was much less sensitive to IGF-I or EGF stimulation. In the metastatic cancer tissues, KCC4 colocalizes with IGF-I or EGF, indicating a likely in vivo stimulation of KCC4 function by growth factors. Thus, blockade of KCC4 trafficking and surface expression may provide a potential target for the prevention of IGF-I- or EGF-dependent cancer spread.
Chen
Yih-Fung
YF
Department of Pharmacology, College of Medicine, Institute of Basic Medical Sciences, National Cheng Kung University, Tainan, Taiwan.
Chou
Cheng-Yang
CY
Wilkins
Robert J
RJ
Ellory
J Clive
JC
Mount
David B
DB
Shen
Meng-Ru
MR
D000328:Adult; D000368:Aged; D045744:Cell Line, Tumor; D002462:Cell Membrane / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000378:metabolism; D005260:Female; D005455:Fluorescent Antibody Technique; D006801:Humans; D007334:Insulin-Like Growth Factor I / Q000378:metabolism; D007834:Lasers; D042282:Microdissection; D008875:Middle Aged; D020409:Molecular Motor Proteins / Q000378:metabolism*; D009361:Neoplasm Invasiveness; D010051:Ovarian Neoplasms / Q000378:metabolism / Q000473:pathology*; D021381:Protein Transport; D034741:RNA, Small Interfering; D020133:Reverse Transcriptase Polymerase Chain Reaction; D027981:Symporters / Q000378:metabolism*; D002583:Uterine Cervical Neoplasms / Q000378:metabolism / Q000473:pathology*; D000096922:K Cl- Cotransporters
D004815:Epidermal Growth Factor; D007334:Insulin-Like Growth Factor I; D020409:Molecular Motor Proteins; D034741:RNA, Small Interfering; D027981:Symporters; C119651:SLC12A7 protein, human; D000096922:K Cl- Cotransporters